FindTrial
Sign In

control group:internal medicine treatment

2 trials

Sponsors

Shulan (Hang zhou) Hospital, The First Affiliated Hospital of Chongqing Medical University

Conditions

Patients with early or mid-stage ACLF/SACLF due to hepatitis B were diagnosed and screened according to the standards set in the "Guidelines for the Diagnosis and Treatment of Liver Failure (2018 Edition)" and also met the indications outlined in the "Expert Consensus on Clinical Application of Artificial Liver Blood Purification Technology (2022 Edition)."chronic hepatitis B

Early Phase 1

Clinical effect and mechanism of fecal microbiota transplantation on HBeAg seroconversion in patients with refractory hepatitis B
Active, not recruitingChiCTR2000040807
Shulan (Hang zhou) Hospitalchronic hepatitis B
Start: 2018-09-01Updated: 2021-04-12

Unknown Phase

The Impact of Artificial Liver on the Levels of Mesenchymal Stem Cell Transdifferentiation Regulatory Factors in Patients with Acute-on-Chronic Liver Failure
Active, not recruitingChiCTR2500098113
The First Affiliated Hospital of Chongqing Medical UniversityPatients with early or mid-stage ACLF/SACLF due to hepatitis B were diagnosed and screened according to the standards set in the "Guidelines for the Diagnosis and Treatment of Liver Failure (2018 Edition)" and also met the indications outlined in the "Expert Consensus on Clinical Application of Artificial Liver Blood Purification Technology (2022 Edition)."
Start: 2022-10-01Updated: 2025-03-10